Corsodyl 1% Oral Gel

Corsodyl is a well-known medicated oral care brand specializing in products containing chlorhexidine digluconate, aimed at treating gingivitis and maintaining oral hygiene. The brand was historically part of the SmithKline Beecham portfolio and later GlaxoSmithKline (GSK).

In 2022, GSK transitioned its consumer healthcare division into a new independent company named Haleon. Consequently, Corsodyl is now owned and managed by Haleon, which is headquartered in the United Kingdom. Manufacturing for the European market typically occurs in specialized pharmaceutical facilities in France or the UK, though distribution spans globally.